The challenge of ensuring elderly people can access their health insurance entitlements: a mixed methods study on the Republic of Srpska’s Protector of Patients’ Health Insurance Entitlements (15 ...

Ensuring adequate and sustainable financing of national immunisation programmes (NIPs) is one of the important elements to achieve the Immunisation Agenda 2030. Many middle-income countries ineligible ...

Amid global conflicts, access to oral health—a vital aspect of well-being—is often overlooked as a critical health priority. Prior to 7 October 2023, Palestinians in the Gaza Strip faced limited ...

High-burden cholera outbreaks, spreading beyond the traditional cholera-endemic countries, have been reported since 2021 in the WHO African region. Member states in the region have committed to the ...

Given the concerning prevalence and large-scale impact of poor perinatal mental health worldwide, there is a growing call for actionable recommendations to promote perinatal mental health and to ...

In October 2021, the WHO recommended the world’s first malaria vaccine—RTS,S/AS01—to prevent malaria in children living in areas with moderate-to-high transmission in sub-Saharan Africa (SSA). A ...

Rising levels of inflation, debt and macrofiscal tightening are putting expenditures on the social sectors including health under immense scrutiny. Already, there are worrying signs of reductions in ...

COVID-19 has posed an unprecedented global health crisis, demanding timely, reliable information on the pandemic’s progression to inform the public and guide decision-making. The WHO’s COVID-19 Weekly ...

The Global Alcohol Action Plan 2022-30 (GAAP) represents an important milestone in policy implementation at the global level on alcohol and health. There has, however, been little attention paid to ...

We write in response to the editorial by Smith et al1 on ‘violence in Palestine’ and the humanitarian crisis in Gaza that has ensued. This one-sided editorial deserves a response that takes a broader ...

Background Several host blood transcriptomic signatures have shown promise as tuberculosis (TB) diagnostic candidates, supporting the use of such biomarkers in prototype RNA-based point-of-care tests.

Introduction Ivermectin and Albendazole (IA) are drug combinations used in mass drug administration (MDA) to halt transmission of lymphatic filariasis (LF) in endemic communities. Safety data on ...